NHIA, Roche FMC Launch Cost-Sharing Initiative For Cancer Treatment

The National Health Insurance Authority, Roche Pharmaceuticals and the Federal Medical Centre, Abuja, have launched a cost-sharing initiative to help cancer patients reduce financial barriers to accessing oncology care.

The partnership is also to enhance cancer care accessibility, improve treatment outcomes, and shield Nigerians from the high costs associated with cancer treatment.

Speaking on Friday in Abuja, during a presentation on the initiative, the NHIA Department of Standards and Quality Assurance Ms Linda Makwe, said the programme was designed to improve access to high-cost oncology medications, especially for vulnerable Nigerians.

She said the partnership showcases NHIA’s role in strategic healthcare purchasing, adding that one of the key objectives was to enhance access to essential, life-saving cancer treatments while ensuring financial sustainability.

“The programme ensures that patients have access to critical oncology drugs at a subsidised rate, with the financial burden shared between Roche, NHIA and the patient,” she said.

She explained that with the agreement, Roche covers 50 per cent of the cost of monoclonal medicines and provides logistical support to ensure drug availability, while NHIA manages patient access and coordinates financing mechanisms.

She noted that the programme also aims to reduce out-of-pocket expenses for patients and aligns with Nigeria’s goal of achieving Universal Health Coverage.